<DOC>
	<DOC>NCT01281371</DOC>
	<brief_summary>Due to the withdrawal of Thelin (Sitaxentan) in December 2010 all patients with pulmonary hypertension treated with Sitaxentan need to be switched to an alternative therapy. This study will observe in which way the change of medication - in the clinical routine, without exception in charge of the treating physician - affects clinical and laboratory parameters and patient's quality of life.</brief_summary>
	<brief_title>Observation Study of the Medication Switch at Patients Treated With Sitaxentan to a Regime Without Sitaxentan</brief_title>
	<detailed_description />
	<mesh_term>Hypertension, Pulmonary</mesh_term>
	<mesh_term>Sitaxsentan</mesh_term>
	<criteria>Pulmonary hypertension Treatment with Sitaxentan Inability or unwillingness to give written informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>